Today is the final trading day of the year will definitely be one that investors will always remember. The market remains in the positive as companies are better positioned for success. From the advance of the Canadian marijuana industry to election of Donald Trump, there will be a lot for investors to watch next year. We would like to highlight some themes anticipated to play out over 2017.
One of the brightest spots of the marijuana industry in 2016 was the Canadian licensed medical marijuana producer sub-sector. In early December, Mettrum Health (MT.V)(MQTRF) and Canopy Growth (CGC.TO)(TWMJF) announced an agreement where Canopy Growth will gain all of the outstanding shares of Mettrum.
Keep your eyes on the marijuana industry as it is expected to see more deals like this over the next year. The possibility for increase consolidation makes these companies attractive investment opportunities: Aphiria (APH.V)(APHQF), Supreme (SL.V)(SPRWF), OrganiGram (OGI.V)(ORGMF), Emblem Corporation (EMC.V), and Aurora Cannabis (ACB.V)(ACBFF).
The biotech sector will be one of the greatest recipients of the legal marijuana movement and recent sector weakness has created opportunities for investors.
GW Pharmaceuticals (GWPH) reported its second Stage Three Clinical trial in September for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). We continue to view GWPH as one of the top marijuana investments due to its capability to convert the cannabis industry through the development of treatments for sickness’ that don’t currently have an approved regimen.
From the financial structure, investors need to conduct with earnestness. We suggest incorporating some guidelines into your investment blueprint.
To end 2016, we want to highlight some of the stocks investors should watch during next year: Emblem Corporation (EMC.V)(EMMBF), Zoned Properties (ZDPY), Aphria (APHQF), Kush Bottles (KSHB), American Cannabis (AMMJ), Aurora (ACBFF), Reliq Healthcare (RQHTF), Zynerba Pharmaceuticals (ZYNE), OrganiGram (OG.V)(ORGMF), Arcturus Grothstar Tech (AGSTF), MassRoots (MSRT), VPR Brands (VPRB), CV Sciences (CVSI), mCig (MCIG), Canopy Growth (TWMJF)(CGC.TO), Medicine Man Tech (MDCL), GW Pharmaceuticals (GWPH), Lexaria (LXRP), Canabo Medical (CMM.V)(CAMDF), Mettrum Health (MT.V), and VinergyRes (VIN.CN).